Cleared Traditional

K222200 - CIRRUS HD-OCT (FDA 510(k) Clearance)

Apr 2023
Decision
262d
Days
Class 2
Risk

K222200 is an FDA 510(k) clearance for the CIRRUS HD-OCT. This device is classified as a Tomography, Optical Coherence (Class II - Special Controls, product code OBO).

Submitted by Carl Zeiss Meditec, Inc. (Dublin, US). The FDA issued a Cleared decision on April 13, 2023, 262 days after receiving the submission on July 25, 2022.

This device falls under the Ophthalmic FDA review panel. Regulated under 21 CFR 886.1570. Viewing, Imaging, Measurement, And Analysis Of Ocular Structures. Diagnostic Device To Aid In The Detection And Management Of Various Ocular Diseases..

Submission Details

510(k) Number K222200 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 25, 2022
Decision Date April 13, 2023
Days to Decision 262 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF

Device Classification

Product Code OBO — Tomography, Optical Coherence
Device Class Class II - Special Controls
CFR Regulation 21 CFR 886.1570
Definition Viewing, Imaging, Measurement, And Analysis Of Ocular Structures. Diagnostic Device To Aid In The Detection And Management Of Various Ocular Diseases.